Peter Gray, Director at Jazz Pharmaceuticals plc (JAZZ), sold 867 shares at $184.06 ($156K) on 2015-08-10, disclosed to the SEC on 2015-08-11.
Open-market sale of $156k JAZZ by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $179.98 | 863 | $155K | 99.5% |
| 2 | $184.06 | 4 | $736 | 0.5% |
| Total | $180.00 avg | 867 | $156K | 100% |
| Filing → |
| JAZZ | SELL | 2022-08-09 | $359K | — | Filing → |
| JAZZ | SELL | 2021-08-10 | $418K | — | Filing → |
| JAZZ | SELL | 2019-08-12 | $214K | — | Filing → |